Skip to main content

Press Room

PSYCHECEUTICAL IN THE PRESS

Topical Ketamine: A Game-Changer for PTSD?

Read Feature

Creating Non-habit Forming Formulations and Treatment Protocols for Psychedelic Substances is Crucial

Read Feature

Topical Ketamine: A Promising New Avenue for PTSD Treatment

Read Feature

Topical NeuroDirect™ Ketamine in the Treatment of Neuropathic Pain Syndromes

Read Feature

New Clinical Trial is Testing a Ketamine Skin Cream for PTSD

Read Feature

Psycheceutical Starts a Phase I Trial With Topical Ketamine

Read Feature

NeuroDirect™ Ketamine: Novel, Non-Systemic Topical Therapy for PTSD & Associated Intractable Depression

Read Feature

Top Biotech Startup 2023 – Psycheceutical: Leveraging the Therapeutic Power of Psychedelics

Read Feature

Psycheceutical’s Topical PTSD Drug Poised for Human Trials

Read Feature

Psycheceutical Developing The First Ever Topical Psychedelic Cream To Treat PTSD

Read Feature

Psycheceutical Listed as 1 of 7 Psychedelic Stocks to Watch

Shark Tank’s Kevin Harrington Invests In Psychedelics Company Psycheceutical

Read Feature

Kevin Harrington Becomes The Latest ‘Shark Tank’ Judge To Enter The Psychedelics Space

Read Feature

Psycheceutical Announces Julian Bailes, M.D. as Principal Medical Advisor

Read Feature

Psycheceutical Bioscience, Inc. Announces Medical Advisory Board

Read Feature

Armed With Two Patents, Psycheceutical Plans To Transform Psychedelic Drug Delivery

Read Feature

Psycheceutical Licenses New Delivery Technologies For Psychedelic Medicines

Read Feature

Biotech Company Earns Two Patents for Targeted Delivery of Psychedelic Medicines

Read Story

Novel Psychedelic Treatment Approach Bypasses Hallucinogenic Effects to Allow Widespread Adoption

Read Story

Psychedelic Business Spotlight: Psycheceutical, Inc., Announces Exclusive License of Two Major Patents

Read Story

PRESS RELEASES

For interviews, media kits or other public relations inquiries, please contact:

press@psycheceutical.com

INTERVIEWS

Chad Harman of Psycheceutical, Sits in the Psychedelic Invest Investor Hotseat

Psycheceutical: Frontiers of Treatment with Dr. Thomas Cabell and Chad Harman

Psycheceutical’s Zappy Zapolin On The Psychedelic Invest Podcast

Psycheceutical’s Chad Harman, On The Street Smart Podcast

GET EMAIL UPDATES FROM PSYCHECEUTICAL, INC.

Fill out the form below to get updates delivered directly to your inbox.